Serge Renaud: from the French paradox to the Cretan miracle - A review of the evidence
A brief profile on Serge Renaud recalls the Lyon Diet Heart Study, in which a Mediterranean pattern after a heart attack was associated with fewer cardiovascular events. The reference historically supports the book's passage, but it is not the primary clinical study. Other trials confirm benefits, with significant methodological and contextual limitations.
- Published 10/11/2026
- Updated 11/11/2026
- Article history
ABSTRACT
The publication analyzed is a brief contribution dedicated to Serge Renaud and the historical context of the so-called French paradox. The full text and abstract are not available in the provided material; therefore, it is not possible to directly reconstruct its methods, data, or quantitative results. In the section "The Choice to Live in Health or Illness" by Dr. A. Colonnese and R. Panzironi, the reference is used to recall the Lyon Diet Heart Study and the hypothesis that a Mediterranean-style diet, rich in plant-based foods and alpha-linolenic acid, can reduce cardiovascular recurrence after a heart attack.
Independent verification identifies the Lyon Diet Heart Study as a randomized secondary prevention trial, meaning it was conducted on people who had already suffered a heart attack. Subsequent studies have observed a lower frequency of major cardiovascular events with Mediterranean models in both primary and secondary prevention. However, systematic reviews highlight heterogeneity between diets, comparisons, and populations, as well as a still limited number of studies with hard clinical outcomes. The book's narrative is therefore moderately confirmed, while the precise figures and the reference to effects after two months require greater caution.
Analyzed study
Serge Renaud: from French paradox to Cretan miracle
DOI: 10.1016/s0140-6736(05)71990-5
PMID: 10615898
The implicit question of the publication is how Serge Renaud's work contributed to linking the so-called French paradox and the Cretan or Mediterranean dietary pattern to cardiovascular prevention. In the book's paragraph, the reference is specifically associated with the Lyon Diet Heart Study, presented as evidence that, following a heart attack, a diet inspired by the Cretan model can reduce cardiovascular events.
The relevance is therefore both historical and scientific: the analyzed contribution recalls the figure of Renaud and the context in which the hypothesis of a protective effect of a Mediterranean diet was developed. However, the publication subject to the Evidence Review does not coincide with the primary Lyon Diet Heart Study. Consequently, it can document the context or the dissemination of the result, but it does not by itself represent a quantitative clinical demonstration of the diet's effect.
Since the text of the publication is not available in the provided material, it is not possible to determine whether it is a biographical profile, an editorial commentary, or a narrative analysis, nor to directly verify which data from the Lyon study are described therein.
Materials and methods of the original study
The title indicates a contribution focused on Serge Renaud, not a clinical trial with enrolled participants. The reference to the Lyon Diet Heart Study present in the book's paragraph must therefore be read as a mention of a distinct clinical research, published by other authors, which is evaluated in the independent evidence.
Results
The book's paragraph attributes a reduction of over 70% in cardiovascular events to the Lyon Diet Heart Study, which used a diet inspired by the Cretan model, low in red meat and dairy products and with a higher intake of alpha-linolenic acid. This is the scientific passage for which the contribution on Renaud was likely included as a contextual reference. The final clinical trial of the Lyon Diet Heart Study, independent of the publication analyzed, involved 605 people following an initial heart attack and reported fewer cardiovascular complications in the group assigned to the Mediterranean model compared to those receiving standard care [1].
The phrase "effects already visible after just two months," however, cannot be verified by the publication analyzed, as its text is not available. Furthermore, clinical cardiovascular outcomes generally require longer observation periods: in the final report of the Lyon study, the mean follow-up was approximately 46 months [1].
Interpretation
In simple terms, the core of the narrative is that changing the set of foods consumed after a heart attack could help reduce the likelihood of new cardiovascular events. The model studied was not simply a “low-fat” diet: it favored plant-based foods, bread, fruit, vegetables, fish, and a rapeseed-based margarine rich in alpha-linolenic acid, while limiting certain animal sources of saturated fats.
The segment documented by the original reference is primarily historical and informative: Renaud is linked to the transition from the French paradox to the testing of a Mediterranean model. The demonstration of the association between diet and fewer recurrences, however, stems from the Lyon Diet Heart Study and subsequent trials. In the Lyon study, the lower number of events in the Mediterranean group is compatible with a causal effect because the participants were assigned to different groups; however, it remains difficult to separate the contribution of each individual food from that of the entire dietary intervention and nutritional support [1].
The research does not prove that red wine is the cause of cardiovascular protection, nor that alpha-linolenic acid alone produces the observed effect. Rather, it demonstrates that an overall dietary program, applied in a specific clinical context, was associated with fewer events compared to the control group.
Independent confirming evidence
The most direct confirmation of the passage in the book is the final report of the Lyon Diet Heart Study. This was a randomized secondary prevention trial involving 605 people who had survived a first heart attack. After an average follow-up of 46 months, the Mediterranean model was associated with a reduction in composite cardiovascular outcomes compared to the control group. This is the evidence closest to the book's statement because it concerns people who had already suffered a heart attack and measures new clinical complications, not just laboratory markers [1]. The main limitation is that it is a single study, conducted in a historical and healthcare context different from the current one.
The PREDIMED trial strengthened the consistency of the narrative in a different context: 7,447 Spanish people with no known cardiovascular disease, but at high risk, were assigned to a Mediterranean diet supplemented with extra virgin olive oil or nuts, or to a low-fat diet. The incidence of the composite endpoint of heart attack, stroke, or cardiovascular death was lower in the two Mediterranean groups: hazard ratio or HR—that is, the ratio between the rate at which events occur in the groups—was 0.69 with extra virgin olive oil and 0.72 with nuts compared to the control [2]. This confirms that a Mediterranean model can reduce major cardiovascular events, but it does not exactly replicate the prevention of recurrences after a heart attack.
Further direct confirmation for secondary prevention comes from the CORDIOPREV trial. In 1,002 people with coronary heart disease, a Mediterranean diet was compared with a low-fat diet for seven years. Major cardiovascular events occurred in 87 participants in the Mediterranean group and in 111 in the low-fat group; adjusted HRs ranged from 0.719 to 0.753, indicating a lower probability of events in the Mediterranean group [3]. The effect was more evident in men; in women, no difference was observed between the groups, an aspect that limits the uniform generalizability of the result [3].
Overall, these studies do not confirm that every component of the diet has an independent effect. Instead, they confirm a consistent direction of effect: structured Mediterranean dietary programs have been associated with a lower frequency of cardiovascular events in experimental settings, especially when compared with usual care or a low-fat diet [1,2,3].
Conflicting evidence
A Cochrane review of 30 randomized trials has urged caution. Regarding secondary prevention, the authors noted that clinical outcomes depended primarily on the Lyon Diet Heart Study and a few other trials, some of which were excluded from the main analyses due to concerns about data reliability. The review judged the evidence regarding the reduction of cardiovascular and all-cause mortality after a heart attack to be of low quality, even while reporting a trend favorable to the Mediterranean model [4].
The same review highlighted that definitions of the “Mediterranean diet,” comparison groups, and the intensity of nutritional support differed substantially between studies. For this reason, a reduction observed in a dietary program cannot be automatically attributed to a single nutrient, red wine, or fat content alone. No sufficiently relevant directly conflicting evidence has been identified that demonstrates an increase in cardiovascular events with a Mediterranean diet; this does not prove the absence of contrary results.
Summary table of evidence
The table distinguishes between the historical-editorial contribution analyzed and independent clinical research that directly evaluates cardiovascular events.
| Reference | Study type | Population or model | Main result | Direction of evidence | Strength of evidence |
|---|---|---|---|---|---|
| Original study | Commentary or editorial profile; text not available | Not reported in available material | References Serge Renaud and the context of the Lyon Diet Heart Study, without verifiable data available. | biologically consistent evidence | preliminary |
| [1] | Secondary prevention RCT | 605 people after a first myocardial infarction | The Mediterranean model was associated with fewer cardiovascular complications during a mean follow-up of 46 months. | direct confirmation | moderate |
| [2] | Primary prevention RCT | 7,447 adults at high cardiovascular risk without known cardiovascular disease | The two Mediterranean diets reduced the incidence of major cardiovascular events compared to the low-fat diet. | indirect confirmation | moderate |
| [3] | Secondary prevention RCT | 1,002 people with coronary heart disease | The Mediterranean diet reduced major cardiovascular events compared to the low-fat diet. | direct confirmation | moderate |
| [4] | Cochrane systematic review of RCTs | 30 trials, primary and secondary prevention | Evidence on clinical outcomes remained limited, heterogeneous, and often of low or very low quality. | discordant evidence | moderate |
Confirmation of the evidence
Claim in the book
In section 1.3 of “The Choice to Live in Health or Illness” by Dr. A. Colonnese and R. Panzironi, the central claim is that the Lyon Diet Heart Study showed a reduction of over 70% in cardiovascular events after a heart attack with a diet inspired by the Cretan model, rich in unsaturated fats such as alpha-linolenic acid and low in dairy and red meat.
Mediterranean dietary pattern → greater presence of plant-based foods and unsaturated fats → modification of the overall dietary profile → lower frequency of cardiovascular events after a heart attack
The publication subject to the Evidence Review was used in the book to support the following passage: Serge Renaud and the Lyon Diet Heart Study are historically linked to the proposal that a Mediterranean-style diet can reduce cardiovascular recurrence after a first heart attack.
The reference analyzed is not the primary publication of the Lyon Diet Heart Study and, since its text is not available, it does not allow for direct verification of the figure reported in the book. However, its inclusion in the "Choosing to Live in Health or Disease" section by Dr. A. Colonnese and R. Panzironi is scientifically understandable as a reference to Renaud's work and the Lyon clinical study.
The core relationship is directly supported by the final report of the Lyon Diet Heart Study: in people who had already suffered a heart attack, the group assigned to a Mediterranean model experienced fewer cardiovascular complications over approximately four years [1]. The same direction of effect has been observed in other contexts: PREDIMED documented fewer major cardiovascular events in high-risk individuals without prior cardiovascular disease [2], while CORDIOPREV observed fewer major events with a Mediterranean diet compared to a low-fat diet in people with coronary heart disease [3].
This convergence strengthens the general narrative, but does not authorize the unreserved transfer of every detail from the historical trial to the general population. The Cochrane review, in fact, noted that, especially in secondary prevention, the number of studies with clinical outcomes was limited and the certainty of the estimates was often low [4].
Overall level of confirmation
MODERATE CONFIRMATION
The narrative is supported by two randomized secondary prevention trials showing fewer cardiovascular events in the Mediterranean group and by a consistent primary prevention trial. The certainty is not absolute because the original reference is an editorial, the dietary interventions are not identical, and systematic reviews indicate heterogeneity and a limited number of comparable clinical studies.
Conclusions
The publication analyzed contributes primarily to the historical context linking Serge Renaud, the French paradox, and the Lyon Diet Heart Study. As its full text is not available, it cannot be used to directly verify clinical results or risk reduction percentages.
The book's narrative is nonetheless moderately supported by independent evidence: the Lyon Diet Heart Study and the CORDIOPREV trial indicate a lower frequency of major cardiovascular events in people with coronary artery disease assigned to a Mediterranean dietary pattern. PREDIMED confirms a favorable trend in primary prevention. Caution remains necessary in separating the role of individual nutrients or foods from the effects of the overall dietary pattern and the nutritional support received.
Overall assessment
The historical connection between Serge Renaud and the Lyon Diet Heart Study is consistent with the book's section. The reduction of cardiovascular events with Mediterranean models is moderately supported by independent randomized trials, especially in secondary prevention. Limitations remain regarding the heterogeneity of interventions, generalizability, and the certainty of the estimates.
References
[1] Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction
[2] Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts
[3] Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial
[4] Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease
Editorial note
Artificial Intelligence was used solely as a tool to support editorial and documentary work. All content, interpretations, bibliographic citations and conclusions have been verified, reviewed and approved by the author, who assumes full scientific responsibility for them.
The manuscript was also subject to independent peer review prior to publication.
To ensure maximum transparency, the article's complete history — including the dates of submission, review, acceptance and publication, as well as information on the peer review process — is available on the dedicated Article History page.